A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects with Type 2 Diabetes Mellitus
CNTO148DML2001 Phase 2a SIMPONI® to Arrest β-cell Loss in Type 1 Diabetes